| 000 | 01681 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250517052846.0 | ||
| 264 | 0 | _c20151229 | |
| 008 | 201512s 0 0 eng d | ||
| 022 | _a0065-2598 | ||
| 024 | 7 |
_a10.1007/978-3-319-18618-4_4 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLucas-Samuel, Sophie | |
| 245 | 0 | 0 |
_aOverview of the Regulatory Oversight Implemented by the French Regulatory Authorities for the Clinical Investigation of Gene Therapy and Cell Therapy Products. _h[electronic resource] |
| 260 |
_bAdvances in experimental medicine and biology _c2015 |
||
| 300 |
_a73-85 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBiological Products _xtherapeutic use |
| 650 | 0 | 4 |
_aCell- and Tissue-Based Therapy _xethics |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aDNA, Recombinant _xtherapeutic use |
| 650 | 0 | 4 |
_aDrug Approval _xlegislation & jurisprudence |
| 650 | 0 | 4 |
_aDrug and Narcotic Control _xlegislation & jurisprudence |
| 650 | 0 | 4 | _aFrance |
| 650 | 0 | 4 |
_aGenetic Therapy _xethics |
| 650 | 0 | 4 |
_aGenetic Vectors _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInvestigational New Drug Application _xlegislation & jurisprudence |
| 650 | 0 | 4 |
_aPatient Safety _xlegislation & jurisprudence |
| 650 | 0 | 4 | _aPractice Guidelines as Topic |
| 650 | 0 | 4 | _aResearch Design |
| 650 | 0 | 4 |
_aTranslational Research, Biomedical _xethics |
| 700 | 1 | _aFerry, Nicolas | |
| 700 | 1 | _aTrouvin, Jean-Hugues | |
| 773 | 0 |
_tAdvances in experimental medicine and biology _gvol. 871 _gp. 73-85 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/978-3-319-18618-4_4 _zAvailable from publisher's website |
| 999 |
_c25265322 _d25265322 |
||